The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration

被引:15
作者
Laine, K
Kivisto, KT
Pelttari, S
Neuvonen, PJ
机构
[1] UNIV HELSINKI, DEPT CLIN PHARMACOL, SF-00250 HELSINKI, FINLAND
[2] ORION FARMOS PHARMACEUT, ANALYT LAB, ESPOO, FINLAND
来源
PHARMACOLOGY & TOXICOLOGY | 1996年 / 79卷 / 05期
关键词
D O I
10.1111/j.1600-0773.1996.tb00272.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of activated charcoal on fluoxetine (40 mg) absorption, with special reference to delayed charcoal administration, was investigated in a randomized study with four parallel groups of eight healthy volunteers. The first group ingested fluoxetine on an empty stomach with water only (control). The second group received 25 g of activated charcoal as a suspension immediately after fluoxetine. The third and fourth groups took fluoxetine with water and received 25 g of charcoal 2 or 4 hr after fluoxetine. Timed blood samples were taken and plasma fluoxetine and norfluoxetine concentrations were measured by GC for 96 hr. When charcoal was administered immediately after fluoxetine, the AUC (0-96 hr) of fluoxetine was reduced by more than 96% (P<0.0005) and the C-max by more than 98% (P<0.0005). The reduction in the AUC (0-96 hr) and C-max of norfluoxetine was similar to that of fluoxetine. When the administration of charcoal was delayed 2 or 4 hr, there was a non-significant mean reduction of 16% and 23% in the AUC (0-96 hr) of fluoxetine. Similarly the C-max was not significantly reduced by charcoal given 2 or 4 hr later. Also, the half-life of fluoxetine was not significantly reduced (by 25%) by the late administration of charcoal. We conclude that activated charcoal, ingested immediately after fluoxetine, practically completely prevents the gastrointestinal absorption of fluoxetine. However, regardless of the relatively slow absorption of fluoxetine, delaying charcoal administration 2-4 hr greatly reduces its antidotal efficacy.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 20 条
[1]   FLUOXETINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN DEPRESSIVE-ILLNESS [J].
BENFIELD, P ;
HEEL, RC ;
LEWIS, SP .
DRUGS, 1986, 32 (06) :481-508
[2]   THE EFFECTS OF FLUOXETINE IN THE OVERDOSE PATIENT [J].
BORYS, DJ ;
SETZER, SC ;
LING, LJ ;
REISDORF, JJ ;
DAY, LC ;
KRENZELOK, EP .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1990, 28 (03) :331-340
[3]  
CROME P, 1977, LANCET, V2, P1203
[4]   THE TOXICITY OF DRUGS USED FOR SUICIDE [J].
CROME, P .
ACTA PSYCHIATRICA SCANDINAVICA, 1993, 87 :33-37
[5]   EFFECT OF DELAYED ADMINISTRATION OF ACTIVATED-CHARCOAL ON NORTRIPTYLINE ABSORPTION [J].
DAWLING, S ;
CROME, P ;
BRAITHWAITE, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (06) :445-447
[6]   REPORT OF A FLUOXETINE FATALITY [J].
KINCAID, RL ;
MCMULLIN, MM ;
CROOKHAM, SB ;
RIEDERS, F .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1990, 14 (05) :327-329
[7]   WHOLE-BOWEL IRRIGATION VERSUS ACTIVATED-CHARCOAL IN SORBITOL FOR THE INGESTION OF MODIFIED-RELEASE PHARMACEUTICALS [J].
KIRSHENBAUM, LA ;
MATHEWS, SC ;
SITAR, DS ;
TENENBEIN, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (03) :264-271
[8]   ABSORPTION INHIBITION AND ENHANCEMENT OF ELIMINATION OF SUSTAINED-RELEASE THEOPHYLLINE TABLETS BY ORAL ACTIVATED-CHARCOAL [J].
LIM, DT ;
SINGH, P ;
NOURTSIS, S ;
DELACRUZ, R .
ANNALS OF EMERGENCY MEDICINE, 1986, 15 (11) :1303-1307
[9]   1993 ANNUAL-REPORT OF THE AMERICAN-ASSOCIATION-OF-POISON-CONTROL-CENTERS TOXIC EXPOSURE SURVEILLANCE SYSTEM [J].
LITOVITZ, TL ;
CLARK, LR ;
SOLOWAY, RA .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1994, 12 (05) :546-584
[10]  
NASH JF, 1982, CLIN CHEM, V28, P2100